Filter Results
:
(330)
Show Results For
-
All HBS Web
(330)
- News (80)
- Research (182)
- Events (1)
- Multimedia (3)
- Faculty Publications (45)
Show Results For
-
All HBS Web
(330)
- News (80)
- Research (182)
- Events (1)
- Multimedia (3)
- Faculty Publications (45)
- 2023
- Article
Dynamic HTA for Digital Health Solutions: Opportunities and Challenges for Patient-Centered Evaluation
By: Jan B. Brönneke, Annika Herr, Simon Reif and Ariel D. Stern
Germany’s 2019 Digital Healthcare Act (Digitale-Versorgung-Gesetz, or DVG) created a number of opportunities for the digital transformation of the health care delivery system. Key among these was the creation of a reimbursement pathway for patient-centered digital...
View Details
Keywords:
Digital Transformation;
Applications and Software;
Product Development;
Insurance;
Policy;
Health Industry;
Germany
Brönneke, Jan B., Annika Herr, Simon Reif, and Ariel D. Stern. "Dynamic HTA for Digital Health Solutions: Opportunities and Challenges for Patient-Centered Evaluation." International Journal of Technology Assessment in Health Care 39, no. 1 (2023).
- 15 Jan 2019
- First Look
New Research and Ideas, January 15, 2019
December 19, 2018 NEJM Catalyst It's Time to Reform the Orphan Drug Act By: Bagley, Nicholas, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern Abstract—No abstract available. Publisher's link:...
View Details
Keywords:
Dina Gerdeman
- March 2008
- Case
Novartis AG: Science-Based Business
By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,...
View Details
Keywords:
Innovation and Invention;
Resource Allocation;
Product Development;
Partners and Partnerships;
Research and Development;
Science-Based Business;
Pharmaceutical Industry
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
- Web
Curriculum - MBA
concerns about unjust research trials in low resource countries, and uncertainty about the value of genetic testing in drug development and study design will be explored. Pediatric Bioethics Pediatric bioethics addresses the complexities...
View Details
- 14 Nov 2017
- First Look
New Research and Ideas: November 14, 2017
authors provide numerous examples of health care organizations that are taking these steps—and seeing impressive results. Publisher's link: https://pubwww.hbs.edu/faculty/Pages/item.aspx?num=53460 forthcoming JAMA Cardiology The Central and Unacknowledged Role of the U.S....
View Details
Keywords:
Carmen Nobel
- Web
Faculty & Advisors - MBA
Kennedy School of Government Mark Fishman, M.D. MS/MBA Program Faculty Co-Chair for MS Professor of Stem Cell and Regenerative Biology at Harvard University, Chief of Pathways Consult Service at Massachusetts General Hospital Douglas...
View Details
- 21 Aug 2007
- First Look
First Look: August 21, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807074 PublicationsPerspectives on Risk and Regulation: The FDA at 100 Author:Arthur A. Daemmrich Publication:Chemical Heritage Press, 2007 Abstract Perspectives on Risk and Regulation: The FDA at 100...
View Details
Keywords:
Martha Lagace
- 11 Oct 2006
- Research & Ideas
The Success of Reverse Leveraged Buyouts
business press and savvy business experts such Warren Buffett. It didn’t help when one of the most publicized RLBOs—Refco—collapsed in 2005 shortly after its initial public offering. And on September 21, a 70-million share offering for View Details
- Research Summary
Overview
In examining the competitive dynamics of R&D strategy, Josh has become particularly interested in how the introduction of new knowledge generated by rivals impacts the direction of R&D efforts. Understanding how new information alters project portfolio decisions is...
View Details
- 05 Sep 2023
- Book
Failing Well: How Your ‘Intelligent Failure’ Unlocks Your Full Potential
In the 1990s, after drugmaker Eli Lilly spent more than a decade and millions of dollars developing the new drug Alimta to treat lung cancer, the medication came up short in effectively treating cancer in expanded trials. While the...
View Details
Keywords:
by Michael Blanding
- 23 Sep 2008
- First Look
First Look: September 23, 2008
claims, and an infusion of new equity financing. The Chapter 11 process has generated both costs and benefits for the company. Its future profitability, and the value of the reorganized business, are both highly uncertain. Purchase the...
View Details
Keywords:
Martha Lagace
- Web
Great American Business Leaders of the 20th Century - Leadership
Publishing Company, 1879–1932 D C. Donald DallasRevere Copper and Brass, 1931–1947 William H. DanforthRalston Purina Company, 1894–1932 Justin DartUnited Drug Company, 1943–1980 Francis B. Davis Jr.United States Rubber Company, 1929–1942...
View Details
- 10 Oct 2007
- First Look
First Look: First Look: October 10
broad-based therapies. Instead, the focus should be on enrolling subpopulations, based on diagnostic testing, in trials of targeted drug treatments and on monitoring and assessing effectiveness after drugs...
View Details
Keywords:
Martha Lagace
- Web
Degrees, Certifications & Alumni Status | About
locations, or onsite with an organization. Harvard Business School grants alumni status with successful completion of any of the following programs: the Advanced Management Program, General Management Program, Owner/President Management,...
View Details
- Web
Curriculum - MBA
build and launch a new product. Reimagining the Future The program is completed in two years and is designed to train future leaders of technology ventures. The MS/MBA Engineering Sciences Program provides a strong foundation in general...
View Details
- Web
Curriculum - Case Method Project
decision; Abolitionists; rise of the Republican Party; Lincoln/Douglas Debates; tariffs; Election of 1860; Southern Secession; Fort Sumter Reconstruction A: The Crisis of 1877 This case provides a general overview of Reconstruction,...
View Details
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
about developing patient-centered therapies that are portable and easy-to-use. Her post-doctoral research was conducted at Harvard Medical School; the Wyss Institute at the Harvard University; and the Institute for Medical Engineering and Science (IMES) at MIT, where...
View Details
- 30 Apr 2024
- Book
When Managers Set Unrealistic Expectations, Employees Cut Ethical Corners
willing to approve continued sales of a drug known to be lethal to some customers in fulfilment of their assigned role to maximise value for shareholders (Armstrong, 1977, p. 204). And so on. Yet, the insights from this research and their...
View Details
Keywords:
by Dina Gerdeman
- 05 Dec 2017
- First Look
First Look at New Research and Ideas, December 5, 2017
S. Fader, Sunil Gupta, Bruce Hardie, Aurelie Lemmens, Barak Libai, David T. Neal, Foster Provost, and Rom Schrift Abstract—In today’s turbulent business environment, customer retention presents a significant challenge for many service companies. Academics have View Details
Keywords:
Sean Silverthorne
- Web
South Asia - Global
participants on the transformative effects of generative AI on teaching and learning methodologies. JANUARY 2024 ALUMNI EVENT Interactive Event with Professor Gunnar Trumbull Alumni relived their HBS days during a case discussion on...
View Details